QLT jumps as regulators clear way for sale of U.S. unit (The Globe and Mail)
U.S. regulators removed a blood testing requirement from its Aczone acne treatment, a treatment owned by U.S. division QLT wants to sell off
Adults also susceptible to acne (The Columbus Dispatch)
NEW YORK -- Acne isn't a problem that magically disappears when you turn 20.
Getting Coverage if Your Employer Doesn't Offer It (Washington Post)
If you don't have an employer plan: The first step is to begin educating yourself about the health insurance market in your state. A good place to start is a Web site run by the Georgetown University Health Policy Institute, http://www.healthinsuranceinfo.net. Click on your state, and you can get...
Acne assaults student's self esteem (Plattsburgh Press Republican)
PLATTSBURGH -- Brandon Bedard watches his feet when he walks the halls of Northeastern Clinton Central School. The high-school senior tries not to talk to people and avoids pep rallies.
QLT to divest acne treatment following FDA ruling (The Globe and Mail)
TORONTO (Reuters) - QLT Inc said on Monday that it would proceed with plans to divest its topical acne treatment Aczone after the U.S. Food and Drug Administration removed key blood monitoring requirements for the treatment.
QLT Gets Screening Requirement Lifted (AP via Yahoo! Finance)
Biotechnology company QLT Inc. said Monday the Food and Drug Administration removed a blood screening and monitoring requirement for its acne treatment, Aczone.
Web Features: Self-Experimenter Freed Himself from Insomnia, Acne and Love Handles (Scientific American)
This is the sixth of eight stories in our Web feature on self-experimenters.
QLT to divest acne treatment following FDA ruling (MSN Money Canada)
TORONTO (Reuters) - QLT Inc (QLT.TO) said on Monday that the U.S. Food and Drug Administration removed key blood monitoring requirements for its topical acne medicine Aczone, clearing a path for the company to divest the treatment.
More News (Daily Breeze)
Sorry, no items are currently available. Acne isn't a problem that magically disappears when you turn 20. Even though it's thought of as a teen skin problem, many adults - in fact, most adults - suffer from at least occasional outbreaks of acne.
Isolagen, Inc. Completes Enrollment In Isolagen Therapy(TM) Phase II/III Acne Scar Study (Medical News Today)
Isolagen(TM), Inc. (Amex: ILE) announced the completion of enrollment of approximately 120 patients in its Phase II/III Study IT-A-008 investigating the Isolagen Therapy(TM) for the treatment of moderate to severe acne scars. Treatments, which will be administered at seven clinical sites across the U.S., have now commenced.
|
